Akèy › Hidradénite suppurative › Ohio
Etid klinik pou Hidradénite suppurative nan Ohio
5 etid pou Hidradénite suppurative ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Optima Research Boardman, Boardman
- Apex Clinical Research Center LLC, Mayfield Heights
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT07665437Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 10, Mayfield Heights
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07828860Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US028, Bexley
- Investigative Site US025, Cincinnati
- Investigative Site US073, Columbus
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06855498A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Apex Clinical Research Center, LLC., Mayfield Heights
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT07244263The Ohio State University Dermatology Biorepository
- OSU Dermatology West, Columbus
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Feb 27, 2026 · NCT03146676Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.